1. Home
  2. BDC vs TNGX Comparison

BDC vs TNGX Comparison

Compare BDC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$114.50

Market Cap

4.5B

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$28.82

Market Cap

5.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
TNGX
Founded
1902
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
5.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
BDC
TNGX
Price
$114.50
$28.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$162.50
$21.78
AVG Volume (30 Days)
557.1K
6.8M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
0.16%
N/A
EPS Growth
23.13
26.89
EPS
1.30
N/A
Revenue
$2,715,194,000.00
$62,384,000.00
Revenue This Year
$8.91
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
$88.78
N/A
Revenue Growth
10.33
48.29
52 Week Low
$101.00
$5.48
52 Week High
$159.99
$34.39

Technical Indicators

Market Signals
Indicator
BDC
TNGX
Relative Strength Index (RSI) 49.57 53.88
Support Level $112.81 $27.65
Resistance Level $122.61 $34.39
Average True Range (ATR) 4.81 2.05
MACD -0.06 -0.25
Stochastic Oscillator 20.70 26.85

Price Performance

Historical Comparison
BDC
TNGX

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: